Patient Centered Experiences in Breast Cancer
Predicting Long-Term Adherence to Tamoxifen Use
Bibliographic Data
| ID | 9099266 |
|---|---|
| Authors | Katherine L Kahn (UCLA Health, corresponding author), Eric C Schneider (0000-0002-1132-5084, Brigham and Women's Hospital), Jennifer L Malin (Amgen (United States)), John Adams (0000-0002-2727-615X, RAND Corporation, corresponding author), John L Adams, Arnold M Epstein (0000-0003-2374-0311, Brigham and Women's Hospital) |
| Year | 2007 |
| Volume | 45 |
| Issue | 5 |
| Pages | 431-439 |
| Publication date | 2007-05-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Medical Care (JOURNAL) |
| Journal identifiers | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Publisher | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/01.mlr.0000257193.10760.7f |
| PMID | 17446829 |
| OpenAlex | W1979710912 |
| Language | EN |
| Citations received | 14 |
| References cited | 34 |
BACKGROUND: Among breast cancer patients, tamoxifen use is associated with reduced risk of disease relapse and death, but it is often difficult for women to sustain therapy during the 5 years required to obtain maximum benefit. OBJECTIVES: We sought to examine the influence of patient-centered care activities on ongoing tamoxifen use 4 years after initiation, we examined key components of patient-centered care and rates of ongoing tamoxifen. METHODS: Using a prospective cohort study that included observational data from the National Initiative for Cancer Care Quality (NICCQ), we studied 881 patients with stage I-III breast cancer who were registered with an initial diagnosis in 1998 by an American College of Surgeons-approved hospital cancer registry in 1 of 5 metropolitan areas, who initiated tamoxifen treatment. A patient survey and medical record abstraction were used as measurements. RESULTS: Among women who initiated tamoxifen, 79% were still taking it 4 years later. Other than older age and the severity of side effects, other demographic, clinical and cancer characteristics, and treatments did not predict ongoing tamoxifen use. In contrast, after adjusting for these factors, the proportion of patients with ongoing tamoxifen use was lower for patients reporting less support than needed (82% vs. 69%, P = 0.0051), less than wanted role in decision-making (80% vs. 70%, P = 0.0486), decision-making about tamoxifen without doctor input (79% vs. 64%, P = 0.0182), and for patients who weren't told about side effects in advance (82% vs. 72%, P = 0.0016). CONCLUSIONS: Although age and the severity of side-effects remain important, patient-centered care was a primary mediator of patient adherence to ongoing cancer treatment with tamoxifen
Breast cancer · Cancer · Cohort · Cohort study · Gynecology · Medical record · Observational study · Prospective cohort study · Tamoxifen · BRCA gene mutations in cancer · Cancer survivorship and care · Internal Medicine · Medication Adherence and Compliance · Medicine · Oncology
The Patient-Centered Care and Receipt of Preventive Services Among Older Adults With Chronic Diseases
A systematic review of evidence on the links between patient experience and clinical safety and effectiveness
Patient-Centered Care and Outcomes
Examining the Role of Patient Experience Surveys in Measuring Health Care Quality
“Nobody Will Tell You. You’ve Got to Ask!”
Medication nonadherence
Predictors of Adherence and Treatment Delays among African American Women Recommended to Receive Breast Cancer Chemotherapy
Patient perceptions of patient‐centred care
When attitudes and beliefs get in the way of shared decision‐making
Exploring the views and experiences of HIV positive patients treated for cancer
On the Road to Improving the Quality of Breast Cancer Care
Attitudinal and social predictors of adherence to oral endocrine therapy
Do patient autonomy preferences matter? Linking patient-centered care to patient-physician relationships and health outcomes
Health information acquisition and lifestyle choices among cancer survivors in China
| Unique citing works | 14 |
|---|---|
| Citations per year | 0,78 |
| Citation span | 2008 - 2025 (18) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 14 |